Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chittaranjan Andrade

Showing results (31-40 of 605) with videos related to

Pageof 61
Sort By:
The Journal of Clinical Psychiatry|March 8, 2014
Selective serotonin reuptake inhibitor drug interactions in patients receiving statinsChittaranjan Andrade
The Journal of Clinical Psychiatry|July 2, 2015
Bioequivalence of generic drugs: a simple explanation for a US Food and Drug Administration requirementChittaranjan Andrade
The Journal of Clinical Psychiatry|July 28, 2016
Cardiometabolic Risks in Schizophrenia and Directions for Intervention, 1: Magnitude and Moderators of the ProblemChittaranjan Andrade
The Journal of ECT|March 2, 2010
Variations on a theme of unmodified electroconvulsive therapy: science or heresy?Chittaranjan Andrade
Indian Journal of Psychological Medicine|August 11, 2018
Prenatal Depression and Infant Health: The Importance of Inadequately Measured, Unmeasured, and Unknown ConfoundsChittaranjan Andrade
The Journal of Clinical Psychiatry|June 2, 2017
Ketamine for Depression, 2: Diagnostic and Contextual IndicationsChittaranjan Andrade
The Journal of Clinical Psychiatry|June 7, 2018
Sedative Hypnotics and the Risk of Falls and Fractures in the ElderlyChittaranjan Andrade
BMJ (Clinical Research Ed.)|October 24, 2007
Rapid tranquillisation in emergency psychiatric settingsChittaranjan Andrade
Archives of Internal Medicine|December 13, 2006
Transcendental meditation and components of the metabolic syndrome: methodological issuesChittaranjan Andrade
The Journal of Clinical Psychiatry|October 11, 2013
Famotidine augmentation in schizophrenia: hope or hype?Chittaranjan Andrade
Pageof 61

Showing results (31-40 of 605) with videos related to

Sort By:
Pageof 61
The Journal of Clinical Psychiatry|March 8, 2014
Selective serotonin reuptake inhibitor drug interactions in patients receiving statinsChittaranjan Andrade
The Journal of Clinical Psychiatry|July 2, 2015
Bioequivalence of generic drugs: a simple explanation for a US Food and Drug Administration requirementChittaranjan Andrade
The Journal of Clinical Psychiatry|July 28, 2016
Cardiometabolic Risks in Schizophrenia and Directions for Intervention, 1: Magnitude and Moderators of the ProblemChittaranjan Andrade
The Journal of ECT|March 2, 2010
Variations on a theme of unmodified electroconvulsive therapy: science or heresy?Chittaranjan Andrade
Indian Journal of Psychological Medicine|August 11, 2018
Prenatal Depression and Infant Health: The Importance of Inadequately Measured, Unmeasured, and Unknown ConfoundsChittaranjan Andrade
The Journal of Clinical Psychiatry|June 2, 2017
Ketamine for Depression, 2: Diagnostic and Contextual IndicationsChittaranjan Andrade
The Journal of Clinical Psychiatry|June 7, 2018
Sedative Hypnotics and the Risk of Falls and Fractures in the ElderlyChittaranjan Andrade
BMJ (Clinical Research Ed.)|October 24, 2007
Rapid tranquillisation in emergency psychiatric settingsChittaranjan Andrade
Archives of Internal Medicine|December 13, 2006
Transcendental meditation and components of the metabolic syndrome: methodological issuesChittaranjan Andrade
The Journal of Clinical Psychiatry|October 11, 2013
Famotidine augmentation in schizophrenia: hope or hype?Chittaranjan Andrade
Pageof 61